28W-94449-01992
3 vaccinations
2 coded responses
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 946 / CA
- Registered
- 2021-03-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Dose 2 — Pfizer-BioNTech
-
2021-03-13
Registered in v-safe
-
2021-03-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-14
-
2021-03-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-03-16
-
2021-03-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-03-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-19
-
2021-03-26
Survey response — day 14, dose 1MedDRA: Paranasal sinus discomfort — Feeling: FairFree text: Sinus pressureMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-26
- 2021-09-10
-
2021-10-25
Dose 3 — Pfizer-BioNTech
- 2022-03-14
-
2022-09-16
Dose 4 — Moderna
-
2022-09-17
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2022-09-18
-
2022-09-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · HeadacheAdult check-in
- 2022-09-20
- 2022-09-21
- 2022-09-25
- 2022-10-02
- 2022-10-07
- 2022-10-14
- 2022-10-21
- 2022-10-28
- 2022-12-21
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 2 | 2021-03-12 | Pfizer-BioNTech | |
| 3 | 2021-10-25 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Moderna | No |
Free text
Release 6 — day 14, dose 1
Symptoms: Sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Paranasal sinus discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release